Logo image of ULY

URGENT.LY INC (ULY) Stock Fundamental Analysis

NASDAQ:ULY - Nasdaq - US9169312074 - Common Stock - Currency: USD

7.18  -0.03 (-0.42%)

Fundamental Rating

2

ULY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. ULY may be in some trouble as it scores bad on both profitability and health. ULY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ULY has reported negative net income.
In the past year ULY has reported a negative cash flow from operations.
In the past 5 years ULY reported 4 times negative net income.
In the past 5 years ULY always reported negative operating cash flow.
ULY Yearly Net Income VS EBIT VS OCF VS FCFULY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -81.42%, ULY is not doing good in the industry: 88.69% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -81.42%
ROE N/A
ROIC N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ULY Yearly ROA, ROE, ROICULY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

ULY has a worse Gross Margin (22.08%) than 81.63% of its industry peers.
ULY's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ULY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
ULY Yearly Profit, Operating, Gross MarginsULY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

2

2. Health

2.1 Basic Checks

ULY does not have a ROIC to compare to the WACC, probably because it is not profitable.
ULY has less shares outstanding than it did 1 year ago.
ULY has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ULY is higher compared to a year ago.
ULY Yearly Shares OutstandingULY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ULY Yearly Total Debt VS Total AssetsULY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ULY has an Altman-Z score of -4.03. This is a bad value and indicates that ULY is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ULY (-4.03) is worse than 80.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.03
ROIC/WACCN/A
WACC10.05%
ULY Yearly LT Debt VS Equity VS FCFULY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

ULY has a Current Ratio of 1.08. This is a normal value and indicates that ULY is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ULY (1.08) is worse than 71.73% of its industry peers.
ULY has a Quick Ratio of 1.08. This is a normal value and indicates that ULY is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.08, ULY is not doing good in the industry: 70.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
ULY Yearly Current Assets VS Current LiabilitesULY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ULY have decreased strongly by -806.56% in the last year.
Looking at the last year, ULY shows a very negative growth in Revenue. The Revenue has decreased by -22.61% in the last year.
The Revenue has been growing by 305.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-806.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.21%
Revenue 1Y (TTM)-22.61%
Revenue growth 3Y336.36%
Revenue growth 5Y305.71%
Sales Q2Q%-22%

3.2 Future

Based on estimates for the next years, ULY will show a very strong growth in Earnings Per Share. The EPS will grow by 27.92% on average per year.
Based on estimates for the next years, ULY will show a quite strong growth in Revenue. The Revenue will grow by 10.35% on average per year.
EPS Next Y77.67%
EPS Next 2Y40.59%
EPS Next 3Y27.92%
EPS Next 5YN/A
Revenue Next Year-3.3%
Revenue Next 2Y6.76%
Revenue Next 3Y10.35%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ULY Yearly Revenue VS EstimatesULY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ULY Yearly EPS VS EstimatesULY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ULY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ULY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ULY Price Earnings VS Forward Price EarningsULY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ULY Per share dataULY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

A more expensive valuation may be justified as ULY's earnings are expected to grow with 27.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.59%
EPS Next 3Y27.92%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ULY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

URGENT.LY INC

NASDAQ:ULY (5/21/2025, 3:57:38 PM)

7.18

-0.03 (-0.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-11 2025-08-11
Inst Owners16.39%
Inst Owner Change-81.59%
Ins Owners9.9%
Ins Owner Change-7.49%
Market Cap8.90M
Analysts80
Price Target12.24 (70.47%)
Short Float %12.45%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-68.47%
Min EPS beat(2)-121.92%
Max EPS beat(2)-15.03%
EPS beat(4)1
Avg EPS beat(4)-29.55%
Min EPS beat(4)-121.92%
Max EPS beat(4)22.51%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)0.68%
Revenue beat(4)2
Avg Revenue beat(4)1.93%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)8.46%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)700%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1500%
EPS NY rev (1m)0%
EPS NY rev (3m)-1388.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-32.54
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)-30.49
FCFYN/A
OCF(TTM)-24.83
OCFYN/A
SpS115.25
BVpS-25.54
TBVpS-32.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.42%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.08%
FCFM N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
F-Score3
Asset Turnover2.64
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 166.19%
Cap/Sales 4.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z -4.03
F-Score3
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)63.32%
Cap/Depr(5y)101.16%
Cap/Sales(3y)2.81%
Cap/Sales(5y)25.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-806.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.21%
EPS Next Y77.67%
EPS Next 2Y40.59%
EPS Next 3Y27.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.61%
Revenue growth 3Y336.36%
Revenue growth 5Y305.71%
Sales Q2Q%-22%
Revenue Next Year-3.3%
Revenue Next 2Y6.76%
Revenue Next 3Y10.35%
Revenue Next 5YN/A
EBIT growth 1Y41.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.68%
EBIT Next 3Y34.93%
EBIT Next 5YN/A
FCF growth 1Y42.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.74%
OCF growth 3YN/A
OCF growth 5YN/A